Page last updated: 2024-10-17

lactic acid and Experimental Hepatoma

lactic acid has been researched along with Experimental Hepatoma in 39 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Follow-up screening was performed in hepatocellular carcinoma with a focused CRISPR library targeting imaging-related genes."1.56Functional Genetic Screening Enables Theranostic Molecular Imaging in Cancer. ( Ackerman, D; Gade, TPF; Johnson, O; Mercadante, M; Perkons, NR; Pilla, G; Profka, E, 2020)
"Tamibarotene (Am80) has good curative effect on advanced hepatocellular carcinoma (HCC)."1.48Tamibarotene-Loaded PLGA Microspheres for Intratumoral Injection Administration: Preparation and Evaluation. ( Gao, J; Huang, G; Tian, L; Yang, Z; Zhang, Z, 2018)
" Unfortunately, the poor bioavailability and hydrophobicity of curcumin pose a major hurdle to its use as a potent anticancer agent."1.40Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals. ( Dua, B; Farazuddin, M; Joshi, B; Khan, AA; Owais, M; Zia, Q, 2014)
"To explore the efficacy of intraperitoneally injected epirubicin (EPI)-loaded poly (d, l)-lactic acid (PLA) microspheres (MS) alone or combined with free epirubicin (FEPI) in treating hepatocellular carcinoma (HCC) in mice."1.35[Efficacy of intraperitoneally injected epirubicin-loaded poly (d, l)-lactic acid microspheres alone or combined with free epirubicin in treating hepatocellular carcinoma in mice]. ( Wang, XM; Ye, SF; Zhang, QQ; Zhou, JY, 2009)
"To introduce an animal model of hepatocellular carcinoma (HCC) in ACI-rats, and to evaluate the therapeutic effects of Poly-lactide-co-glycolide (Plcg) -microspheres in the transarterial chemoembolization (TACE) in this model, as well the value of this model in the experiments of interventional therapy."1.32Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. ( Claussen, C; Eul, T; Graepler, F; Huppert, P; Pereira, P; Qian, J; Truebenbach, J; Wiemann, G, 2003)
"In contrast to the hepatoma cells, rat and human hepatocytes exhibited higher rates of anaerobic glycolysis in the presence of fructose and thus were able to maintain their viability under these conditions."1.28Differences in glycolytic capacity and hypoxia tolerance between hepatoma cells and hepatocytes. ( Anundi, I; de Groot, H; Hugo-Wissemann, D; Lauchart, W; Viebahn, R, 1991)
"Lactic acid was either produced or utilized, depending on the arterial whole-blood concentration."1.27Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats. ( Dauchy, RT; Sauer, LA, 1983)

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19907 (17.95)18.7374
1990's11 (28.21)18.2507
2000's10 (25.64)29.6817
2010's10 (25.64)24.3611
2020's1 (2.56)2.80

Authors

AuthorsStudies
Perkons, NR1
Johnson, O1
Pilla, G1
Profka, E1
Mercadante, M1
Ackerman, D1
Gade, TPF1
Tian, L1
Gao, J2
Yang, Z1
Zhang, Z1
Huang, G1
Brinkhoff, B1
Ostroumov, D1
Heemcke, J1
Woller, N1
Gürlevik, E1
Manns, MP1
Longerich, T1
Zender, L1
Harty, JT1
Kubicka, S1
Kühnel, F1
Wirth, TC1
Farazuddin, M1
Dua, B1
Zia, Q1
Khan, AA1
Joshi, B1
Owais, M1
Gong, Y1
Wang, Z1
Dong, G1
Sun, Y1
Wang, X1
Rong, Y1
Li, M1
Wang, D1
Ran, H1
Choi, JW1
Park, JH1
Baek, SY1
Kim, DD1
Kim, HC1
Cho, HJ1
Zhu, D1
Tao, W1
Zhang, H1
Liu, G1
Wang, T1
Zhang, L1
Zeng, X1
Mei, L1
Wilkins, LR1
Brautigan, DL1
Wu, H1
Yarmohammadi, H1
Kubicka, E1
Serbulea, V1
Leitinger, N1
Liu, W1
Haaga, JR1
Eisenbrey, JR1
Soulen, MC1
Wheatley, MA1
Zhou, JY2
Wang, XM2
Zhang, QQ2
Ye, SF2
Chen, ZK1
Cai, MX1
Yang, J1
Lin, LW1
Xue, ES1
Huang, J1
Wei, HF1
Zhang, XJ1
Ke, LM1
Yuneva, MO1
Fan, TW1
Allen, TD1
Higashi, RM1
Ferraris, DV1
Tsukamoto, T1
Matés, JM1
Alonso, FJ1
Wang, C1
Seo, Y1
Chen, X1
Bishop, JM1
Meijsing, B1
Carbó, N3
López-Soriano, FJ3
Argilés, JM3
Qian, J1
Truebenbach, J1
Graepler, F1
Pereira, P1
Huppert, P1
Eul, T1
Wiemann, G1
Claussen, C1
Dong, AJ1
Deng, LD1
Sun, DX1
Zhang, YT1
Jin, JZ1
Yuan, YJ1
Liu, X1
Heng, WS1
Li, Q1
Chan, LW1
Weinberg, BD1
Blanco, E1
Lempka, SF1
Anderson, JM1
Exner, AA1
Weng, J1
Hou, ZQ1
Zhou, ZM1
Engel, F1
Sauer, LA3
Dauchy, RT3
Stayman, JW1
Ronen, SM1
Volk, A1
Mispelter, J1
Javaux, F1
Vincent, MF1
Wagner, DR1
van den Berghe, G1
Anghileri, LJ1
Maincent, P1
Thouvenot, P1
Cordova-Martinez, A1
Stubbs, M2
Rodrigues, L1
Howe, FA1
Wang, J1
Jeong, KS1
Veech, RL1
Griffiths, JR2
Ciftci, K1
Hincal, AA1
Kas, HS1
Ercan, TM1
Sungur, A1
Guven, O1
Ruacan, S1
Robinson, SP1
Rodrigues, LM1
Parkins, CS1
Collingridge, DR1
Bastian, P1
Bartkowski, R1
Köhler, H1
Kissel, T1
Busquets, S1
Alvarez, B1
van Royen, M1
Bink, H1
Felipe, A1
Ko, YH1
Pedersen, PL1
Geschwind, JF1
Louis, NA1
Witters, LA1
Hugo-Wissemann, D1
Anundi, I1
Lauchart, W1
Viebahn, R1
de Groot, H1
Mumper, RJ1
Ryo, UY1
Jay, M1
Matsuno, T2
Arora, KK1
Smith, R1
Williams, JF1
Yamashita, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study[NCT02938546]Phase 3200 participants (Anticipated)Interventional2016-11-30Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

39 other studies available for lactic acid and Experimental Hepatoma

ArticleYear
Functional Genetic Screening Enables Theranostic Molecular Imaging in Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 09-01, Volume: 26, Issue:17

    Topics: Animals; Carbon-13 Magnetic Resonance Spectroscopy; Carcinoma, Hepatocellular; CRISPR-Cas Systems; D

2020
Tamibarotene-Loaded PLGA Microspheres for Intratumoral Injection Administration: Preparation and Evaluation.
    AAPS PharmSciTech, 2018, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzoates; Drug Liberation; Female; Injections, Intralesional; Lacti

2018
Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers.
    European journal of immunology, 2014, Volume: 44, Issue:4

    Topics: Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cytokines; Flow Cytometry; I

2014
Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Cell Survival; Curcumin; Drug C

2014
Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits.
    Drug delivery, 2016, Volume: 23, Issue:7

    Topics: Animals; Apoptosis; Doxorubicin; Drug Delivery Systems; Lactic Acid; Liver; Liver Neoplasms; Liver N

2016
Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
    Colloids and surfaces. B, Biointerfaces, 2015, Aug-01, Volume: 132

    Topics: Animals; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Doxorubicin; Drug Carriers; La

2015
Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Acta biomaterialia, 2016, Volume: 30

    Topics: Animals; Carcinoma, Hepatocellular; Docetaxel; Drug Delivery Systems; Hep G2 Cells; Humans; Indoles;

2016
Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma.
    Cardiovascular and interventional radiology, 2017, Volume: 40, Issue:3

    Topics: Acrylates; Animals; Caffeic Acids; Cell Line, Tumor; Coumaric Acids; Disease Models, Animal; Emboliz

2017
Delivery of encapsulated Doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents.
    IEEE transactions on bio-medical engineering, 2010, Volume: 57, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Contrast Media; Doxorubicin; Drug Delivery Systems; Drug Scree

2010
[Efficacy of intraperitoneally injected epirubicin-loaded poly (d, l)-lactic acid microspheres alone or combined with free epirubicin in treating hepatocellular carcinoma in mice].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2009, Volume: 31, Issue:5

    Topics: Animals; Delayed-Action Preparations; Epirubicin; Infusions, Parenteral; Lactic Acid; Liver Neoplasm

2009
Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:1

    Topics: Angiopoietin-2; Animals; Antineoplastic Agents; Delayed-Action Preparations; Docetaxel; Drug Carrier

2012
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
    Cell metabolism, 2012, Feb-08, Volume: 15, Issue:2

    Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Transformation, Neoplastic; Citric Acid Cycle; DN

2012
Effects of the phosphodiesterase-IV inhibitor EMD 95832/3 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Cancer letters, 2002, Dec-15, Volume: 188, Issue:1-2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue; Alanine; Animals; Blood Glucose; Cachexia; Cell

2002
Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.
    World journal of gastroenterology, 2003, Volume: 9, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therap

2003
[Studies on paclitaxel-loaded nanoparticles of amphiphilic block copolymer].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2004, Volume: 39, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Delayed-Action Preparations; Drug Carriers; Drug Deliver

2004
Novel polymeric microspheres containing norcantharidin for chemoembolization.
    Journal of controlled release : official journal of the Controlled Release Society, 2006, Volume: 116, Issue:1

    Topics: Alginates; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma 256, W

2006
Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment.
    Journal of biomedical materials research. Part A, 2007, Volume: 81, Issue:1

    Topics: Absorbable Implants; Animals; Antibiotics, Antineoplastic; Catheter Ablation; Doxorubicin; Drug Deli

2007
[Treatment of hepatocellular carcinoma in mice with locally administered epirubicin-loaded poly(D, L)-lactic acid microspheres].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2006, Volume: 28, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Delayed-Action Preparations; Drug Carriers; Epirubicin; Inject

2006
The effect of membrane filters on cultured cells.
    The Journal of pharmacy and pharmacology, 1982, Volume: 34, Issue:5

    Topics: Animals; Cell Division; Cells, Cultured; DNA; Ethanol; Glucose; HeLa Cells; Humans; Lactates; Lactic

1982
Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats.
    Cancer research, 1983, Volume: 43, Issue:8

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Amino Acids; Animals; Fasting; Female; Glucose; Glutamine; Hyd

1983
Amino acid, glucose, and lactic acid utilization in vivo by rat tumors.
    Cancer research, 1982, Volume: 42, Issue:10

    Topics: Amino Acids; Animals; Blood Glucose; Carcinoma 256, Walker; Female; Kinetics; Lactates; Lactic Acid;

1982
Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors.
    NMR in biomedicine, 1994, Volume: 7, Issue:6

    Topics: Alanine; Animals; Cell Differentiation; Cell Division; Energy Metabolism; Glucose; Glutamic Acid; La

1994
Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.
    The Biochemical journal, 1995, Feb-01, Volume: 305 ( Pt 3)

    Topics: Adenosine Kinase; Aminoimidazole Carboxamide; Animals; Dihydroxyacetone; Erythrocytes; Fructosephosp

1995
Liver calcium homeostasis modification by iron: a probable factor in its carcinogenesis.
    Neoplasma, 1994, Volume: 41, Issue:4

    Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Radioisotopes; Cell Transformation, Neoplastic; Fe

1994
Lactate release and uptake in hepatoma 7288CTC perfused in situ with L-[(U)-14C]lactate or D-[(U)-14C]glucose.
    Metabolism: clinical and experimental, 1994, Volume: 43, Issue:12

    Topics: Animals; Blood Flow Velocity; Blood Glucose; Carbon Radioisotopes; Glucose; Lactates; Lactic Acid; L

1994
Metabolic consequences of a reversed pH gradient in rat tumors.
    Cancer research, 1994, Aug-01, Volume: 54, Issue:15

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carbonates; Cell Membrane Permeability; Hydr

1994
Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
    Pharmaceutical development and technology, 1997, Volume: 2, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Biodegradation, Environmental; Chemistry, Pharmaceutical;

1997
The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a.
    British journal of cancer, 1998, Volume: 78, Issue:11

    Topics: Administration, Inhalation; Animals; Carbon Dioxide; Glucose; Hydrogen-Ion Concentration; Lactic Aci

1998
Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 1998, Volume: 46, Issue:3

    Topics: Animals; Biocompatible Materials; Chemotherapy, Cancer, Regional Perfusion; Disease Models, Animal;

1998
Lack of effect of the cytokine suppressive agent FR167653 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Cancer letters, 2000, Aug-31, Volume: 157, Issue:1

    Topics: Adipose Tissue; Alanine; Animals; Anorexia; Blood Glucose; Cachexia; Cell Division; Female; Interleu

2000
Hepatic transport of gluconeogenic substrates during tumor growth in the rat.
    Cancer investigation, 2001, Volume: 19, Issue:3

    Topics: Alanine; Animals; Diffusion; Disease Progression; Female; Glucose; Glycerol; Kinetics; Lactic Acid;

2001
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.
    Cancer letters, 2001, Nov-08, Volume: 173, Issue:1

    Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Survival; Deoxyglucose; Drug Delivery Systems;

2001
Glucose regulation of acetyl-CoA carboxylase in hepatoma and islet cells.
    The Journal of biological chemistry, 1992, Feb-05, Volume: 267, Issue:4

    Topics: 3-O-Methylglucose; Acetyl-CoA Carboxylase; Alkaline Phosphatase; Animals; Bacterial Proteins; Blotti

1992
Differences in glycolytic capacity and hypoxia tolerance between hepatoma cells and hepatocytes.
    Hepatology (Baltimore, Md.), 1991, Volume: 13, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Anaerobiosis; Animals; Carci

1991
Neutron-activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:11

    Topics: Animals; Biodegradation, Environmental; Brachytherapy; Holmium; Lactates; Lactic Acid; Liver Neoplas

1991
End products of glutamine oxidation in MC-29 virus-induced chicken hepatoma mitochondria.
    Biochemical medicine and metabolic biology, 1989, Volume: 42, Issue:2

    Topics: Animals; Aspartate Aminotransferases; Aspartic Acid; Chickens; Citric Acid Cycle; Glutamates; Glutam

1989
Oxidation of cytosolic NADH by the malate-aspartate shuttle in MC29 hepatoma cells.
    Cell biology international reports, 1989, Volume: 13, Issue:9

    Topics: Aminooxyacetic Acid; Animals; Aspartic Acid; Chickens; Cytosol; Glutamine; Lactates; Lactic Acid; Li

1989
"Pyruvate recycling" and its influence on the estimation of the pentose pathway in intact liver and Morris hepatoma 5123TC cells.
    The International journal of biochemistry, 1987, Volume: 19, Issue:2

    Topics: Animals; Carbon Radioisotopes; Dicarboxylic Acids; Dihydroxyacetone Phosphate; Female; Glucose; Gluc

1987
[Experimental study of an anticancer drug delivery system using polylactic acid].
    Nihon Geka Gakkai zasshi, 1987, Volume: 88, Issue:4

    Topics: Animals; Antineoplastic Agents; Delayed-Action Preparations; Fluorouracil; Infusion Pumps; Lactates;

1987